| Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma (NCT00624702) | Novartis | 2008-02-01 |
| Pharmacokinetic Study on Raltegravir and Lamotrigine (NCT00618241) | Radboud University Medical Center | 2008-02-01 |
| Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric Acid (NCT00961259) | Mutual Pharmaceutical Company, Inc. | 2008-02-01 |
| CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma (NCT00634751) | University of Wisconsin, Madison | 2008-02-01 |
| Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma (NCT00591058) | TransMolecular | 2008-02-01 |
| Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer (NCT00624182) | Akita University Hospital | 2008-02-01 |
| Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects (NCT00822003) | University Hospital, Basel, Switzerland | 2008-02-01 |
| A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744 (NCT00659191) | GlaxoSmithKline | 2008-02-01 |
| A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges (NCT00651352) | GlaxoSmithKline | 2008-02-01 |
| Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects (NCT01365624) | American Regent, Inc. | 2008-02-01 |
| Safety Assessment of a Multipeptide-gene Vaccine in CML (NCT00455221) | Tehran University of Medical Sciences | 2008-02-01 |
| Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors (NCT00618735) | Biogen | 2008-02-01 |
| Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy Volunteers (NCT02217514) | Boehringer Ingelheim | 2008-02-01 |
| A Phase I/II Trial of VR-CHOP in Lymphoma Patients (NCT00634179) | Emory University | 2008-02-01 |
| Satraplatin and Vinorelbine in Advanced Solid Tumors (NCT01220284) | Southern Europe New Drug Organization | 2008-02-01 |
| A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors. (NCT00651365) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-02-01 |
| Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours (NCT00697879) | Chroma Therapeutics | 2008-02-01 |
| Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas (NCT00621556) | Massachusetts General Hospital | 2008-02-01 |
| Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis (NCT00620919) | Massachusetts General Hospital | 2008-02-01 |
| Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma (NCT00520533) | Ludwig Institute for Cancer Research | 2008-02-01 |
| A Safety and Pharmacokinetic Study of Proellex® (NCT00619385) | Repros Therapeutics Inc. | 2008-02-01 |
| Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma (NCT00634452) | Bristol-Myers Squibb | 2008-02-01 |
| Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults (NCT00618605) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| A Phase 1 Study in Patients With Solid Tumors (NCT01215916) | Eli Lilly and Company | 2008-02-01 |
| Preventing Depression in the Children of Depressed African American Mothers (NCT00904917) | Children's Hospital of Philadelphia | 2008-02-01 |
| Far Infrared Radiation Treatment of Dementia and Other Mental Illness (NCT00574054) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation (NCT00773201) | Assistance Publique - Hôpitaux de Paris | 2008-02-01 |
| A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED) (NCT00944671) | Johnson & Johnson Consumer and Personal Products Worldwide | 2008-02-01 |
| A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors (NCT00612703) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2008-02-01 |
| Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle (NCT00636519) | Emergent BioSolutions | 2008-02-01 |
| Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer (NCT00632333) | Teikyo University | 2008-02-01 |
| Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes (NCT00633997) | Novartis | 2008-02-01 |
| A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age (NCT00645346) | Novartis Vaccines | 2008-02-01 |
| Therapies for Salivary Flux Stimulation in Patients Transplanted With Hematopoietic Stem Cells (NCT00929825) | Federal University of Minas Gerais | 2008-02-01 |
| GSK1247303 First Time in Human Study (NCT00651079) | GlaxoSmithKline | 2008-02-01 |
| A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes (NCT00607503) | Jaeb Center for Health Research | 2008-02-01 |
| Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers (NCT00626158) | University of California, San Francisco | 2008-02-01 |
| Study of AZD8931 in Patients With Advanced Solid Malignancies (NCT00637039) | AstraZeneca | 2008-02-01 |
| Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma (NCT00792467) | Italfarmaco | 2008-02-01 |
| Low-frequency Transcranial Magnetic Stimulation To Enhance Motor Recovery In The Subacute Phase After Stroke (NCT01333579) | University of Sao Paulo General Hospital | 2008-02-01 |
| Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280 (NCT00681746) | AstraZeneca | 2008-02-01 |
| A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients (NCT00690287) | AstraZeneca | 2008-02-01 |
| Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis (NCT00628433) | Harbor Therapeutics | 2008-02-01 |
| In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer (NCT00631072) | Beth Israel Deaconess Medical Center | 2008-02-01 |
| The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement (NCT00576134) | University Hospital, Strasbourg, France | 2008-02-01 |
| Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients (NCT00808860) | Hanoi Medical University | 2008-02-01 |
| A Phase I Trial of Bortezomib and Sunitinib (NCT00720148) | Emory University | 2008-02-01 |
| Embryo Transfer: Embryo Expulsion and Outcome (NCT00905788) | Royan Institute | 2008-02-01 |
| Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer (NCT00701857) | University of Arizona | 2008-02-01 |
| A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus (NCT00642538) | Mannkind Corporation | 2008-02-01 |
| Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia (NCT00643981) | TCA Cellular Therapy | 2008-02-01 |
| PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers (NCT00622375) | Bausch Health Americas, Inc. | 2008-02-01 |
| Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) (NCT00624728) | University Hospital, Bordeaux | 2008-02-01 |
| Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen (NCT01719133) | Anergis | 2008-02-01 |
| Phase I Study in RAD 001 Patients With Relapse AML (NCT01074086) | French Innovative Leukemia Organisation | 2008-02-01 |
| Deep Transcranial Magnetic Stimulation (TMS)- Treatment for Post Traumatic Stress Disorder (NCT00517400) | Hadassah Medical Organization | 2008-02-01 |
| Energy Specific Far Infrared Radiation Treatment for AIDS (NCT00574522) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer (NCT00630110) | Nereus Pharmaceuticals, Inc. | 2008-02-01 |
| Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites (NCT00664352) | Renovo | 2008-02-01 |
| A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer (NCT00663832) | Novartis Pharmaceuticals | 2008-02-01 |
| Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325 (NCT00681720) | AstraZeneca | 2008-02-01 |
| Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL) (NCT00981708) | University of Athens | 2008-02-01 |
| Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex (NCT01323465) | Jazz Pharmaceuticals | 2008-02-01 |
| Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT00639834) | Bristol-Myers Squibb | 2008-02-01 |
| Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma (NCT00560352) | Bristol-Myers Squibb | 2008-02-01 |
| Cognitive Interventions and Nutritional Supplementation for Patients With Long-lasting Back Pain (NCT00463970) | NORCE Norwegian Research Centre AS | 2008-02-01 |
| Pilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic Encephalopathy (NCT00620711) | Vanderbilt University | 2008-02-01 |
| Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors (NCT01151384) | INSYS Therapeutics Inc | 2008-02-01 |
| A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease (NCT00607308) | Pfizer | 2008-02-01 |
| Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease (NCT00633841) | Affiris AG | 2008-02-01 |
| ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis (NCT02629224) | Astellas Pharma Inc | 2008-02-01 |
| Investigation of the Metabolism and Pharmacokinetics of [14C]BI 1744 CL and [14C]BI 1744 CL Administered as an Oral Solution in Healthy Male Subjects (NCT02172157) | Boehringer Ingelheim | 2008-02-01 |
| A First Time in Human Study of GSK586529 in Healthy Volunteers (NCT00703547) | GlaxoSmithKline | 2008-01-28 |
| Ebola and Marburg Virus Vaccines (NCT00605514) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-25 |
| Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer (NCT00543335) | M.D. Anderson Cancer Center | 2008-01-25 |
| Bevacizumab and Temsirolimus in Patients With Advanced Malignancy (NCT00610493) | M.D. Anderson Cancer Center | 2008-01-25 |
| Gastric Cancer RAD001 Study (NCT01514110) | Chinese University of Hong Kong | 2008-01-23 |
| Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors (NCT00572078) | Safi Shahda | 2008-01-23 |
| Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects (NCT00700076) | Yale University | 2008-01-22 |
| Effects of Smoking on Opioid Receptor Binding: A PET Study (NCT00618631) | National Institute on Drug Abuse (NIDA) | 2008-01-17 |
| Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer (NCT00575952) | Gynecologic Oncology Group | 2008-01-17 |
| To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males (NCT00599612) | GlaxoSmithKline | 2008-01-17 |
| A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects (NCT00625859) | GlaxoSmithKline | 2008-01-16 |
| Bioequivalence and Food Effect of 250mg of Lamotrigine XR (NCT00605371) | GlaxoSmithKline | 2008-01-15 |
| The Pharmacokinetic Interaction Between Amlodipine and Losartan (NCT03912285) | Korea University Anam Hospital | 2008-01-10 |
| PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP (NCT00598390) | National Institute of Mental Health (NIMH) | 2008-01-08 |
| Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC (NCT00602030) | Syndax Pharmaceuticals | 2008-01-08 |
| Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults (NCT00671814) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2008-01-06 |
| Lucentis for New Onset Neovascular Glaucoma (NCT00727038) | University of Illinois at Chicago | 2008-01-04 |
| Intensity Modulated Radiotherapy for Breast Cancer (NCT00594477) | Washington University School of Medicine | 2008-01-04 |
| Intrathecal Enzyme Replacement for Hurler Syndrome (NCT00638547) | Masonic Cancer Center, University of Minnesota | 2008-01-02 |
| AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT00535353) | NCIC Clinical Trials Group | 2008-01-02 |
| Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects (NCT00615212) | GlaxoSmithKline | 2008-01-02 |
| A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy. (NCT00629876) | Takeda | 2008-01-01 |
| A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NCT00534027) | Amgen | 2008-01-01 |
| Paclitaxel and Irinotecan in Advanced Gastric Cancer (NCT01136031) | Seoul National University Hospital | 2008-01-01 |
| Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects (NCT02183467) | Boehringer Ingelheim | 2008-01-01 |
| GI-4000 With Adoptive Transfer in Pancreatic Cancer (NCT00837135) | University of Pennsylvania | 2008-01-01 |
| Smoke-Free Living Study (NCT00832806) | University of British Columbia | 2008-01-01 |
| Fast & Fed Pharmacokinetic (PK) Study (NCT00692016) | Bayer | 2008-01-01 |